Brazil Threatens To Break Merck’s Efavirenz Patent

Law360, New York (April 26, 2007, 12:00 AM EDT) -- Brazil on Wednesday reportedly threatened to break Merck & Co. Inc.’s patent on HIV/AIDS drug Efavirenz, warning it will tap into India’s generic drug industry if the pharmaceutical giant will not offer the country a lower price for the much-needed medicine.

Health Minister Jose Gomes Temporao on Wednesday identified Efavirenz, an antiretroviral drug used to treat HIV and AIDS, as a "public interest" medicine and gave Merck one week to negotiate a discounted price with the Brazilian government, the Associated Press reported.

If negotiations fail, Brazil...
To view the full article, register now.